ARCHIVES

Community Center Group To Consider “Clinical Standards, Medical Audit”

This article is from The Cancer Letter archive.

Vol. 01 No. 32 | September 13, 1974

Download PDF Visit The Full Archive

Related Articles

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

First NCAB “Road” Hearing In L.A.

September 18, 1987

Varmus’s 2016 Bypass Budget Seeks “Modest” Increase of $823 Million

December 5, 2014

CCIRC Members Now Feel At Home In DCT

March 3, 1978

Deep Budget Cuts Poised to Kick in March 1; Hill Insiders See Little Hope for Deal

February 15, 2013